Figure 2From: DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I studyEstimated percentage change from baseline in (a) iAUC 60 , (b) Ktrans, and (c) T2* mean.Back to article page